Audit of Medicaid Select Diabetes and Weight Loss Drugs
Medicaid utilization of and gross spending on select diabetes and weight loss drugs have rapidly increased in recent years. The select diabetes drugs were approved to help control blood sugar levels for individuals with type 2 diabetes; however, these drugs are known to be used for weight loss. Most States cover these drugs to treat Medicaid enrollees with diabetes. Additionally, some States cover similar types of drugs that were approved for weight loss. We will identify national Medicaid utilization for select diabetes and weight loss drugs and select one or more States to review.
Announced or Revised | Agency | Title | Component | Report Number(s) | Expected Issue Date (FY) |
---|---|---|---|---|---|
March 2024 | Centers for Medicare and Medicaid Services | Audit of Medicaid Select Diabetes and Weight Loss Drugs | Office of Audit Services | WA-24-0036 (W-00-24-35911) | 2025 |